Sunday 11 October 2026 Export all NVO data to Excel Powerpack

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024. In the quarter to June 2026, revenue grew 4.47%, EPS fell 18.7%, free cash flow grew 71.6% and total debt rose 44.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for five.

38.64 0.46 +1.20%

Follow NVO

Alert me

Market cap: $127.8B
P/E: 9.4×
Fwd P/E: —
Dividend yield: 4.65%
F-score: 5/9
Altman Z: 4.32
Beneish M: −2.51
Dividend safety: 46/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	60.84%	74.07%	61.81%	68.91%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	5	5	4
ROA Full definition →	22.00%	24.29%	20.71%	22.03%
ROIC Full definition →	28.67%	28.59%	27.38%	33.99%
Return on Tangible Assets Full definition →	58.25%	70.54%	62.02%	69.35%
Average Days of Receivables Full definition →	119.76	112.52	105.33	113.04
Free Cash Flow per Share Full definition →	1.72	1.10	0.99	2.12
Free Cash Flow Full definition →	7,610.53	4,863.47	4,388.93	9,416.60
Capital Expenditures Full definition →	(12,814.25)	(13,470.33)	(13,643.11)	(9,564.48)
Other line items
Cash ROIC Full definition →	11.92%	8.28%	8.08%	19.20%
Accounts Receivable Turnover Full definition →	3.44	3.65	3.58	3.57
Accounts Payable Turnover Full definition →	3.02	3.63	2.48	2.31
Inventory Turnover Full definition →	1.33	1.31	1.32	1.30
Average Days of Payables Full definition →	83.55	91.86	122.67	161.91
Days of Inventory on Hand Full definition →	294.06	318.66	308.10	321.75
Tax Rate Full definition →	(0.22)	(0.22)	(0.22)	(0.21)
Research and Development Expense of Revenue Full definition →	17.54%	15.77%	16.84%	16.33%
Selling, General and Administrative Expense of Revenue Full definition →	19.64%	20.49%	22.74%	23.22%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	1.96%	0.00%
Interest Coverage Full definition →	69.27	27.52	18.83	11.73
Operating CF/Net income Full definition →	1.12	0.96	1.16	1.24
Depreciation/Fixed assets Full definition →	0.12	0.10	0.11	0.11
Capex/Depreciation Full definition →	(3.08)	(4.03)	(4.10)	(2.91)
Revenue per Share Full definition →	11.60	11.47	10.53	10.51
Operating CF per Share Full definition →	4.60	4.13	4.06	4.27
Capex per Share Full definition →	(2.89)	(3.03)	(3.07)	(2.15)
Capex to Sales Full definition →	0.25	0.26	0.29	0.20

Show all line items

Columns are period end dates

Stockrow Weekly